Gøril_sep_2015.jpg
Photo: Bjørn-Kåre Iversen

Flag icon Flag icon

Gøril Eide Flaten

Professor
Farmasiija instituhtta




Arbeider i CRIStin


  • Falavigna, Margherita; Klitgaard, Mette; Steene, Erik; Flaten, Gøril Eide. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability. European Journal of Pharmaceutical Sciences 2019; Volum 132. ISSN 0928-0987.s 44 - 54.s doi: 10.1016/j.ejps.2019.02.035.

  • Falavigna, Margherita; Klitgaard, Mette; Brase, Christina; Ternullo, Selenia; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development. International Journal of Pharmaceutics 2018; Volum 537 (1-2). ISSN 0378-5173.s 213 - 222.s doi: 10.1016/j.ijpharm.2017.12.038.

  • Berben, Philippe; Bauer-Brandl, Annette; Brandl, Martin; Faller, Bernard; Flaten, Gøril Eide; Jacobsen, Ann-Cathrine; Brouwers, Joachim; Augustijns, Patrick. Drug permeability profiling using cell-free permeation tools: Overview and applications. European Journal of Pharmaceutical Sciences 2018; Volum 119. ISSN 0928-0987.s 219 - 233.s doi: 10.1016/j.ejps.2018.04.016.

  • Ternullo, Selenia; Basnet, Purusotam; Holsæter, Ann Mari; Flaten, Gøril Eide; de Weerd, Louis; Skalko-Basnet, Natasa. Deformable liposomes for skin therapy with human epidermal growth factor: The effect of liposomal surface charge. European Journal of Pharmaceutical Sciences 2018; Volum 125. ISSN 0928-0987.s 163 - 171.s doi: 10.1016/j.ejps.2018.10.005.

  • Ternullo, Selenia; de Weerd, Louis; Flaten, Gøril Eide; Holsæter, Ann Mari; Skalko-Basnet, Natasa. The isolated perfused human skin flap model: A missing link in skin penetration studies?. European Journal of Pharmaceutical Sciences 2017; Volum 96. ISSN 0928-0987.s 334 - 341.s doi: 10.1016/j.ejps.2016.10.003.

  • Ternullo, Selenia; de Weerd, Louis; Holsæter, Ann Mari; Flaten, Gøril Eide; Skalko-Basnet, Natasa. Going skin deep: a direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model. European journal of pharmaceutics and biopharmaceutics 2017; Volum 121. ISSN 0939-6411.s 14 - 23.s doi: 10.1016/j.ejpb.2017.09.006.

  • Kumari, Jaya; Flaten, Gøril Eide; Skalko-Basnet, Natasa; Tveiten, Helge. Molecular transfer to Atlantic salmon ovulated eggs using liposomes. Aquaculture 2017; Volum 479. ISSN 0044-8486.s 404 - 411.s doi: 10.1016/j.aquaculture.2017.06.019.

  • Andersen, Toril; Mishchenko, Ekaterina; Flaten, Gøril Eide; Sollid, Johanna U Ericson; Mattsson, Sofia; Tho, Ingunn; Skalko-Basnet, Natasa. Chitosan-based nanomedicine to fight genital Candida infections: Chitosomes. (fulltekst) Marine Drugs 2017; Volum 15:64 (3). ISSN 1660-3397.s 1 - 12.s doi: 10.3390/md15030064.

  • Engesland, André; Skalko-Basnet, Natasa; Flaten, Gøril Eide. In vitro models to estimate drug penetration through the compromised stratum corneum barrier. Drug Development and Industrial Pharmacy 2016; Volum 42 (11). ISSN 0363-9045.s 1742 - 1751.s doi: 10.3109/03639045.2016.1171334.

  • Engesland, André; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Phospholipid Vesicle-Based Permeation Assay and EpiSkin in Assessment of Drug Therapies Destined for Skin Administration. Journal of Pharmaceutical Sciences 2015; Volum 104 (3). ISSN 0022-3549.s 1119 - 1127.s doi: 10.1002/jps.24315.

  • Naderkhani, Elenaz; Vasskog, Terje; Flaten, Gøril Eide. Biomimetic PVPA in vitro model for estimation of the intestinal drug permeability using fasted and fed state simulated intestinal fluids. European Journal of Pharmaceutical Sciences 2015; Volum 73. ISSN 0928-0987.s 64 - 71.s doi: 10.1016/j.ejps.2015.03.017.

  • Flaten, Gøril Eide; Palac, Zora; Engesland, André; Filipović-Grčić, Jelena; Vanić, Željka; Skalko-Basnet, Natasa. In vitro skin models as a tool in optimization of drug formulation. European Journal of Pharmaceutical Sciences 2015; Volum 75. ISSN 0928-0987.s 10 - 24.s doi: 10.1016/j.ejps.2015.02.018.

  • Andersen, Toril; Bleher, Stefan; Flaten, Gøril Eide; Tho, Ingunn; Mattsson, Sofia; Skalko-Basnet, Natasa. Chitosan in Mucoadhesive Drug Delivery: Focus on Local Vaginal Therapy. Marine Drugs 2015; Volum 13 (1). ISSN 1660-3397.s 222 - 236.s doi: 10.3390/md13010222.

  • Naderkhani, Elenaz; Erber, Astrid; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Improved Permeability of Acyclovir: Optimization of Mucoadhesive Liposomes Using the Phospholipid Vesicle-Based Permeation Assay. Journal of Pharmaceutical Sciences 2014; Volum 103 (2). ISSN 0022-3549.s 661 - 668.s doi: 10.1002/jps.23845.

  • Fulsundar, Shweta; Harms, Klaus; Flaten, Gøril Eide; Johnsen, Pål Jarle; Chopade, Balu Ananda; Nielsen, Kaare Magne. Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation. Applied and Environmental Microbiology 2014; Volum 80 (11). ISSN 0099-2240.s 3469 - 3483.s doi: 10.1128/AEM.04248-13.

  • Naderkhani, Elenaz; Isaksson, Johan; Ryzhakov, Alexey; Flaten, Gøril Eide. Development of a biomimetic phospholipid vesicle-based permeation assay for the estimation of intestinal drug permeability. Journal of Pharmaceutical Sciences 2014; Volum 103 (6). ISSN 0022-3549.s 1882 - 1890.s doi: 10.1002/jps.23954.

  • Palac, Zora; Engesland, André; Flaten, Gøril Eide; Skalko-Basnet, Natasa; Filipovic-Grcic, Jelena; Vanic, Zeljka. Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development. Journal of liposome research 2014; Volum 24 (4). ISSN 0898-2104.s 313 - 322.s doi: 10.3109/08982104.2014.899368.

  • Engesland, André; Skar, Merete L.; Hansen, Terkel; Skalko-Basnet, Natasa; Flaten, Gøril Eide. New Applications of Phospholipid Vesicle-Based Permeation Assay: Permeation Model Mimicking Skin Barrier. Journal of Pharmaceutical Sciences 2013; Volum 102 (5). ISSN 0022-3549.s 1588 - 1600.s doi: 10.1002/jps.23509.

  • Whitaker, Ragnhild; Ingebrigtsen, Sveinung Gaarden; Naderkhani, Elenaz; Skar, Merete L.; Flaten, Gøril Eide. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin. Journal of liposome research 2013; Volum 23 (4). ISSN 0898-2104.s 298 - 310.s doi: 10.3109/08982104.2013.805338.

  • Andersen, Toril; Vanic, Zeljka; Flaten, Gøril Eide; Mattsson, S.; Tho, Ingunn; Skalko-Basnet, Natasa. Pectosomes and Chitosomes as Delivery Systems for Metronidazole: The One-Pot Preparation Method. Pharmaceutics 2013; Volum 5. ISSN 1999-4923.s 445 - 456.s doi: 10.3390/pharmaceutics5030445.

  • Flaten, Gøril Eide; Chang, Ting-Tung; Phillips, William T.; Brandl, Martin; Bao, Ande; Goins, Beth. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution. Journal of liposome research 2013; Volum 23 (1). ISSN 0898-2104.s 70 - 81.s doi: 10.3109/08982104.2012.742537.

  • Tørfoss, Veronika; Isaksson, Johan; Ausbacher, Dominik; Brandsdal, Bjørn Olav; Flaten, Gøril Eide; Anderssen, Trude; Cavalcanti Jacobsen, Cristiane de Albuquerque; Havelkova, Martina; Nguyen, Leonard T.; Vogel, Hans J.; Strøm, Morten B.. Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic b2,2-amino acid. Journal of Peptide Science 2012; Volum 18 (10). ISSN 1075-2617.s 609 - 619.s doi: 10.1002/psc.2441.

  • Hansen, Terkel; Ausbacher, Dominik; Flaten, Gøril Eide; Havelkova, Martina; Strøm, Morten B.. Synthesis of Cationic Antimicrobial beta(2,2)-Amino Acid Derivatives with Potential for Oral Administration. Journal of Medicinal Chemistry 2011; Volum 54 (3). ISSN 0022-2623.s 858 - 868.s doi: 10.1021/jm101327d.

  • Fischer, Sarah Maud; Flaten, Gøril Eide; Hagesæther, Ellen; Fricker, Gert; Brandl, Martin. In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants. Journal of Pharmacy and Pharmacology (JPP) 2011; Volum 63 (8). ISSN 0022-3573.s 1022 - 1030.s doi: 10.1111/j.2042-7158.2011.01301.x.

  • Fischer, Sarah Maud; Flaten, Gøril Eide; Hagesæter, Ellen; Fricker, Gert; Brandl, Martin. In Vitro Permeability of Poorly Water Soluble Drugs in the Phospholipid Vesicle-Based Permeation Assay (PVPA): The Influence of Non-Ionic Surfactants. Journal of Pharmacy and Pharmacology (JPP) 2011 (63). ISSN 0022-3573.s 1022 - 1030.

  • Flaten, Gøril Eide; Kottra, Gabor; Stensen, Wenche; Isaksen, Geir Villy; Karstad, Rasmus Tørnes; Svendsen, John Sigurd; Daniel, Hannelore; Svenson, Johan. In Vitro Characterization of Human Peptide Transporter hPEPT1 Interactions and Passive Permeation Studies of Short Cationic Antimicrobial Peptides. Journal of Medicinal Chemistry 2011; Volum 54 (7). ISSN 0022-2623.s 2422 - 2432.s doi: 10.1021/jm1015704.

  • Isaksson, Johan; Brandsdal, Bjørn Olav; Engqvist, Stig Olov Magnus; Flaten, Gøril Eide; Svendsen, John Sigurd; Stensen, Wenche. A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption. Journal of Medicinal Chemistry 2011; Volum 54 (16). ISSN 0022-2623.s 5786 - 5795.s doi: 10.1021/jm200450h.

  • Kanzer, Johanna; Tho, Ingunn; Flaten, Gøril Eide; Mägerlein, Markus; Hölig, Peter; Fricker, Gert; Brandl, Martin. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. Journal of Pharmacy and Pharmacology (JPP) 2010; Volum 62 (11). ISSN 0022-3573.s 1591 - 1598.s doi: 10.1111/j.2042-7158.2010.01172.x.

  • Brandl, Martin; Flaten, Gøril Eide; Bauer-Brandl, Annette. Passive Diffusion Across Membranes. John Wiley & Sons 2009 ISBN 978-0-471-75477-0.s 541 - 550.

  • Svenson, Johan; Karstad, Rasmus Tørnes; Flaten, Gøril Eide; Brandsdal, Bjørn Olav; Brandl, Martin; Svendsen, John Sigurd. Altered Activity and Physicochemical Properties of Short Cationic Antimicrobial Peptides by Incorporation of Arginine Analogues. Molecular Pharmaceutics 2009; Volum 6 (3). ISSN 1543-8384.s 996 - 1005.s doi: 10.1021/mp900057k.

  • Flaten, Gøril Eide; Awoyemi, Opeyemi Linda Ronke; Luthman, Kristina; Brandl, Martin; Massing, U.. The Phospholipid Vesicle-Based Drug Permeability Assay: 5. Development Toward an Automated Procedure for High-Throughput Permeability Screening. Journal of the Association for Laboratory Automation 2009; Volum 14 (1). ISSN 1535-5535.s 12 - 21.s doi: 10.1016/j.jala.2008.04.002.

  • Flaten, Gøril Eide; Luthman, Kristina; Vasskog, Terje; Brandl, Martin. Drug permeability across a phospholipid vesicle-based barrier: 4. The effect of tensides, co-solvent and pH changes on barrier integrity and on drug permeability. European Journal of Pharmaceutical Sciences 2008; Volum 34 (2-3). ISSN 0928-0987.s 173 - 180.s doi: 10.1016/j.ejps.2008.04.001.

  • Flaten, Gøril Eide; Skar, Merete L.; Luthman, Kristina; Brandl, Martin. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability. European Journal of Pharmaceutical Sciences 2007; Volum 30. ISSN 0928-0987.s 324 - 332.s doi: 10.1016/j.ejps.2006.11.017.

  • Flaten, Gøril Eide. Legemidlers permeabilitet over en liposombasert barriere: En ny in vitro-metode for å studere passiv diffusjon. Norsk Farmaceutisk Tidsskrift 2006; Volum 114 (1). ISSN 0029-1935.s 27 - 28.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion. European Journal of Pharmaceutical Sciences 2006; Volum 27 (1). ISSN 0928-0987.s 80 - 90.

  • Flaten, Gøril Eide; Bunjes, Heike; Luthman, Kristina; Brandl, Martin. Drug permeability across a phospholipid vesicle-based barrier - 2. Characterization of barrier structure, storage stability and stability towards pH changes. European Journal of Pharmaceutical Sciences 2006; Volum 28. ISSN 0928-0987.s doi: 10.1016/j.ejps.2006.03.008.

  • Sætern, Ann Mari; Flaten, Gøril Eide; Brandl, Martin. A method to determine the incorporetion capacity of camptothecin in liposomes. AAPS PharmSciTech 2004; Volum 5 (3). ISSN 1530-9932.

  • Sætern, Ann Mari; Flaten, Gøril Eide; Brandl, Martin. A Method to Determine the Incorporation Capacity of Camptothecin in Liposomes. AAPS PharmSciTech 2004; Volum 5 (3). ISSN 1530-9932.s 1 - 7.

  • Falavigna, Margherita; Klitgaard, Mette; Steene, Erik; Flaten, Gøril Eide. Simulating the intestinal environment with the mucus-PVPA in vitro model: the impact of pH and simulated intestinal fluids on drug permeability. 1st Nordic-POP Annual Meeting 2019-01-14 - 2019-01-16 2019.

  • Falavigna, Margherita; Klitgaard, Mette; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Mucus-PVPA: an in vitro permeability screening tool for the investigation of intestinal drug absorption. 3rd European Conference on Pharmaceutics 2019-03-25 - 2019-03-26 2019.

  • Falavigna, Margherita; Klitgaard, Mette; Steene, Erik; Flaten, Gøril Eide. Simulating the intestinal environment with the mucus-PVPA in vitro model: the impact of pH and simulated intestinal fluids on drug permeability.. UNGAP Spring meeting 2019 2019-02-12 - 2019-02-13 2019.

  • Flaten, Gøril Eide; Øvreberg, Elisabeth. 42 millioner kroner for utvikling av persontilpasset medisin. 2018.

  • Flaten, Gøril Eide. Hvordan velge de beste kandidatene for fremtidens legemidler?. 2018.

  • Flaten, Gøril Eide; Hauan, Marit Anne; Ringvold, Geir Hevnskjel. Observatoriet. 2018.

  • Flaten, Gøril Eide; Hauan, Marit Anne; Ringvold, Geir Hevnskjel. Jubileumspodcast. 2018.

  • Falavigna, Margherita; Brase, Christina; Klitgaard, Mette; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Mucus-PVPA : a permeability-screening tool for drug discovery and formulation development in mucosal tissues. First all WGs UNGAP Meeting. Intestinal absorption: what is happening inside and beyond? 2018-03-08 - 2018-03-09 2018.

  • Falavigna, Margherita; Klitgaard, Mette; Brase, Christina; Ternullo, Selenia; Skalko-Basnet, Natasa; Flaten, Gøril Eide. The mucus-PVPA (phospholipid vesicle-based permeation assay) as a permeability-screening tool to elucidate essential drug properties in drug discovery and formulation development in mucosal tissues. Northern Pharma Network and Nordic POP Kick off-meeting 2018 2018-01-29 - 2018-01-31 2018.

  • Flaten, Gøril Eide. Drug permeability across biological barriers estimated by the PVPA. Norecopa’s 10 year Anniversary 2017-10-08 - 2017-10-08 2017.

  • Flaten, Gøril Eide. PVPA in drug screening and formulation development. Invitert foredrag 2017-09-01 - 2017-09-01 2017.

  • Ternullo, Selenia; de Weerd, Louis; Holsæter, Ann Mari; Flaten, Gøril Eide; Skalko-Basnet, Natasa. A Nano-Approach to Improve Local Skin Therapy: Isolated Perfused Human Skin Flap as a Tool in Optimization. 2017 AAPS Annual Meeting and Exposition 2017-11-12 - 2017-11-15 2017.

  • Hansen, Anette Holte; Flaten, Gøril Eide. Så lenge holder solkremen din. 2017.

  • Falavigna, Margherita; Brase, Christina; Klitgaard, Mette; Skalko-Basnet, Natasa; Flaten, Gøril Eide. How is mucus influencing drug permeability in the PVPA?. 6th FIP Pharmaceutical Sciences World Congress 2017-05-21 - 2017-05-24 2017.

  • Ternullo, Selenia; de Weerd, Louis; Flaten, Gøril Eide; Holsæter, Ann Mari; Skalko-Basnet, Natasa. Isolated perfused human skin flap model: a novel tool to evaluate drug penetration through the skin II. The 8th National PhD Conference in Medical Imaging 2016-11-21 - 2016-11-22 2016.

  • Ternullo, Selenia; de Weerd, Louis; Flaten, Gøril Eide; Holsæter, Ann Mari; Skalko-Basnet, Natasa. Isolated perfused human skin flap model: a novel tool to evaluate drug penetration through the skin. The 8th National PhD Conference in Medical Imaging 2016-11-21 - 2016-11-22 2016.

  • Flaten, Gøril Eide; Øvreberg, Elisabeth. Er det sant at solkrem slutter å virke etter 1 år?. 2016.

  • Flaten, Gøril Eide. Jo, man kan bruke solkrem fra i fjor. 2016.

  • Flaten, Gøril Eide. Hvor lenge holder solkrem seg?. 2016.

  • Flaten, Gøril Eide. Er det sant at vi må kaste solkrem etter ett år?. 2016.

  • Flaten, Gøril Eide. Hvor lenge er solkrem holdbar?. 2016.

  • Naderkhani, Elenaz; Engesland, André; Skalko-Basnet, Natasa; Flaten, Gøril Eide. The Phospholipid vesicle-based permeation assay (PVPA) to determine drug permeability across different biological barriers. Nordic Innovative Drug Delivery meeting 2016-06-01 - 2016-06-03 2016.

  • Ternullo, Selenia; de Weerd, Louis; Flaten, Gøril Eide; Holsæter, Ann Mari; Skalko-Basnet, Natasa. Isolated perfused human skin flap model: A novel tool to evaluate drug penetration through the skin. Skin Forum 2016 Annual Meeting 2016-06-21 - 2016-06-22 2016.

  • Flaten, Gøril Eide; Øvreberg, Elisabeth. Er det sant at man må kaste solkremen etter ett år?. 2016.

  • Flaten, Gøril Eide. Skammelig nedprioritering av forskning på kvinnesykdommer. Tidsskrift for kjønnsforskning 2016. ISSN 0809-6341.

  • Flaten, Gøril Eide. Skammelig nedprioritering. Nordlys 2016. ISSN 0805-5440.

  • Øvreberg, Elisabeth; Flaten, Gøril Eide; Skalko-Basnet, Natasa. Er kvinnesykdommer mindre viktige?. 2016.

  • Kumari, Jaya; Flaten, Gøril Eide; Skalko-Basnet, Natasa; Tveiten, Helge. Liposomes: a vehicle for molecular/passive transport in salmon eggs. 5th International Workshop on Biology of Fish Gametes (IWBFG) 2015-09-07 - 2015-09-11 2015.

  • Ternullo, Selenia; de Weerd, Louis; Mercer, James; Flaten, Gøril Eide; Holsæter, Ann Mari; Skalko-Basnet, Natasa. Isolated perfused human skin flap model: Innovative approach to improve skin therapy. 24th Liposome Workshop Ameland 2015-10-05 - 2015-10-09 2015.

  • Flaten, Gøril Eide. Økt kunnskap gir grunnlag for utvikling og innovasjon. 2015.

  • Naderkhani, Elenaz; Flaten, Gøril Eide. Development of biomimetic phospholipid vesicle-based permeation assays (PVPA) as screening tool in drug development. 2015 ISBN 978-82-7589-462-3.

  • Palac, Zora; Engesland, André; Flaten, Gøril Eide; Skalko-Basnet, Natasa; Vanic, Zeljka. Optimization of dermal drug delivery nanosystems. 5th Croatian Congress on Pharmacy 2015-05-21 - 2015-05-24 2015.

  • Øvergård, Renate Alsén; Naderkhani, Elenaz; Flaten, Gøril Eide. Finner de beste legemidlene – uten dyreforsøk. 2015.

  • Palac, Zora; Engesland, André; Flaten, Gøril Eide; Skalko-Basnet, Natasa; Filipovic-Grcic, Jelena; Vanic, Zeljka. Assesment of liposomes for trans(dermal) drug delivery: The skin-PVPA as a novel in vitro model for the stratum corneum. Central European Symposium on Pharmaceutical Technology 2014-09-18 - 2014-09-20 2014.

  • Engesland, André; Riaz, Samia; Fedreheim, Elena; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Artificial in vitro models mimicking healthy and compromised skin. Liposome research days 2014-08-04 - 2014-08-07 2014.

  • Engesland, André; Riaz, Samia; Fedreheim, Elena; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Artificial in vitro model mimicking burned skin. Liposome Research Days 2014: Living Innovation 2014-08-04 - 2014-08-07 2014.

  • Naderkhani, Elenaz; Erber, Astrid; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Improved permeability of acyclovir: Optimization of mucoadhesive liposomes using the PVPA model. Liposome Research Days 2014: Living Innovation 2014-08-04 - 2014-08-07 2014.

  • Naderkhani, Elenaz; Erber, Astrid; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Improved permeability of acyclovir: Optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 2014-03-31 - 2014-04-04 2014.

  • lynch, matt; Flaten, Gøril Eide. How long before it hits?. 2014.

  • Engesland, André; Riaz, Samia; Fedreheim, Elena; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Artificial in vitro model mimicking burned skin. World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 2014-03-31 - 2014-04-03 2014.

  • Flaten, Gøril Eide. Webpages for Drug Transport and Delivery Research Group. 2012.

  • Flaten, Gøril Eide. Legemidler og barrierer. 2012.

  • Flaten, Gøril Eide. Hermer stoffopptak via hud og tarm. 2012.

  • Flaten, Gøril Eide. Impuls. Imouls 2012-03-01 - 2012.

  • Naderkhani, Elenaz; Engesland, André; Ryzhakov, Alexey; Flaten, Gøril Eide. The phospholipid vesicle-based permeation assay (PVPA) for screening of drug permeability. CRS Nordic 2012-06-03 - 2012.

  • Naderkhani, Elenaz; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Improved prediction of intestinal permeability using the phospholipid vesicle-based permeation assay. 9th Central European Symposium on Pharmaceutical Technology 2012-09-20 - 2012-09-22 2012.

  • Engesland, André; Skar, Merete L.; Hansen, Terkel; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Development of an artificial in vitro permeation skin model. 9th Central Symposium on Pharmaceutical Technology 2012-09-20 - 2012.

  • Isaksson, Johan; Flaten, Gøril Eide; Brandsdal, Bjørn Olav; Svendsen, John Sigurd. Studies of Small Synthetic Anti-microbial Peptides by NMR and Molecular Modeling. Joint EUROMAR 2010 + ISMAR 2010 2010-07-05 - 2010-07-09 2010.

  • fischer, sarah; Flaten, Gøril Eide; Brandl, Martin; Fricker, Gert. The effects of various non-ionic surfactants on the permeation of nadolol across Caco-2 cell monolayers and Phospholipid vesicle-based barriers. AAPS Annel Meeting and Exposition 2009-09-01 - 2009.

  • fischer, sarah; Flaten, Gøril Eide; Luthman, Kristina; Fricker, Gert; Brandl, Martin. Oral bioavailability screening: Comparison of the Phospholipid vesicle-based permeation barrier with the Caco-2 cell model. Phospholipid Symposium 2009-03-01 - 2009.

  • Flaten, Gøril Eide; Luthman, Kristina; Vasskog, Terje; Brandl, Martin. The phospholipid vesicle-based barrier: Effect of solubility enhancing agents and pH changes on barrier integrity and on drug permeability. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 2008-04-07 - 2008-04-11 2008.

  • Flaten, Gøril Eide; Luthman, Kristina; Vasskog, Terje; Brandl, Martin. The phospholipid vesicle-based barrier: Effect of pH changes, tensides and co-solvents on barrier integrity and on drug permeability. 2nd midnightsun meeting on drug transport and delivery 2008-06-25 - 2008-06-27 2008.

  • Flaten, Gøril Eide; Awoyemi, Opeyemi Linda Ronke; Luthman, Kristina; Brandl, Martin; Massing, U.. Development towards an automated drug permeability assay based on immobilized phospholipid vesicles. AAPS 2008 2008-11-16 - 2008-11-20 2008.

  • Flaten, Gøril Eide; Bunjes, Heike; Luthman, Kristina; Brandl, Martin. Drug permeability across a phospholipid vesicle based barrier: barrier structure characterization and effect of agitation on barrier integrity and drug permeability. CRS 2007 2007-07-07 - 2007-07-11 2007.

  • Flaten, Gøril Eide. Virkestoffers permeabilitet over en liposombasert barriere: en ny metode for å studere passiv diffusjon. Norsk Farmasøytisk Tidsskrift 2007 (12).s 25 - 26.

  • Flaten, Gøril Eide. The Phospholipid Vesicle-Based Barrier, A Novel Method For Passive Drug Permeability Screening. 2007 ISBN 978-82-7589-179-0.

  • Flaten, Gøril Eide; Skar, Merete L.; Luthman, Kristina; Brandl, Martin. The phospholipid vesicle based barrier; a model for drug permeability screening. PSWC 2007 2007-04-22 - 2007-04-25 2007.

  • Flaten, Gøril Eide; Luthman, Kristina; Brandl, Martin. Virkestoffers permeabilitet over en liposombasert barriere: en ny metode for å studere passiv diffusjon. Farmasidagen 2007 2007-10-25 - 2007-10-27 2007.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. The phospholipid vesicle based barrier: a novel in vitro model for studying passive drug permeability. EUFEPS/AAPS Conference on Optimisation of Drug-Like Properties of Leads in Discovery: Fine-Tuning the Physchem-Biopharmaceutical-ADME-Tox Profile 2006-03-01 - 2006-03-03 2006.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. The phospholipid vesicle based membrane: a novel in vitro model for studying passive drug permeability. Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 2006-03-26 - 2006-03-30 2006.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. A Novel in vitro Model for Studying Passive Drug Permeability / Absorbability: The Phospholipid Vesicle-Based Membrane. Annual Meeting of the Controlled Release Society 2006-07-22 - 2006-07-26 2006.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. The phospholipid vesicle based membrane, a novel model for studying passive drug permeability. 1st PharmSciFair 2005-06-12 - 2005-06-17 2005.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. LEGEMIDDLERS PERMEABILITET OVER EN LIPOSOMBASERT BARRIERE: EN NY METODE FOR Å STUDERE PASSIV DIFFUSJON. Farmasidagene 2005 2005-10-27 - 2005-10-29 2005.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. THE PHOSPHOLIPID VESICLE BASED MEMBRANE: A NOVEL MODEL FOR STUDYING PASSIVE DRUG PERMEABILITY. Farmasidagene 2005 2005-10-27 - 2005-10-29 2005.

  • Flaten, Gøril Eide; Sætern, Ann Mari; Brandl, Martin. Camptothecin-Lactone Incorporation in Liposomes - A Phase Solubility Study. International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 2004-03-27 - 2004-03-30 2004.

  • Sætern, Ann Mari; Flaten, Gøril Eide; Brandl, Martin. Incorporation Efficacy of Camptothecin into Liposomes. 2004 AAPS Annuel Meeting and Exposition 2004-11-07 - 2004-11-07 2004.

  • Sætern, Ann Mari; Sveinbjørnsson, Baldur; Flaten, Gøril Eide; Brandl, Martin. Camptothecin-in-liposomes: Incorporation capacity and in vitro cytotoxicity. The Midnight Sun Meeting on Drug Transport and Drug Delivery 2004-07-01 - 2004-07-03 2004.

  • Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin. A NEW APPROACH FOR MEASURING DRUG PERMEABILITY ACROSS PHOSPHOLIPID MEMBRANES. The Midnight Sun Meeting on Drug Transport and Drug Delivery 2004-07-01 - 2004-07-03 2004.

  • Flaten, Gøril Eide. Incorporation of Camptothecin in liposomes, method devlopment and incorporation efficacy screening using different liposome formulations. 2003.

  • Member of research group